Concepedia

Publication | Open Access

Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer

DOIFull Paper Access

118

Citations

14

References

2009

Year

Alberto Sobrero, Stephen P. Ackland, Stephen Clarke, R. Pérez-Carrión, Silvia Chiara, J. Gapski, Paul N. Mainwaring, Bernd Langer, Scott Young
Oncology

Abstract

Bevacizumab combined with first-line FOLFIRI is an effective and well-tolerated therapy option for patients with metastatic CRC.

References

YearCitations

Page 1